Clinical trial
A Prospective Single-arm Investigation to Assess the Efficacy, of Topical "Nåva" Foot Cream for 8 Weeks of Treatment in Patients With Mild to Moderate Tinea Pedis Interdigitalis and Heal Cracks, Calluses and/or Dry Feet.
NCT03676686 is registered in ClinicalTrials.gov with Natumin Pharma AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Single-arm Investigation to Assess the Efficacy, of Topical "Nåva" Foot Cream for 8 Weeks of Treatment in Patients With Mild to Moderate Tinea Pedis Interdigitalis and Heal Cracks, Calluses and/or Dry Feet.
- Lead sponsor
- Natumin Pharma AB
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 1, 2018
- Completion date
- November 4, 2019
- Enrollment
- 46 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.